EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access

Efficacy of a Multimodal Digital Behavior Change Intervention on Lifestyle Behavior, Cardiometabolic Biomarkers, and Medical Expenditure: Protocol for a Randomized Controlled Trial

Sakeina Howard-Wilson iD, Jack Ching iD, Sherri Gentile iD, Martin Ho iD, Alex Garcia iD, Didem Ayturk iD, Peter Lazar iD, Nova Hammerquist iD, David McManus iD, Bruce Barton iD, Steven Bird iD, John Moore iD und 1 weitere

JMIR Research Protocols · 2024

DOI: 10.2196/50378 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, 2024. Verfasst von Sakeina Howard-Wilson und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States. Hauptthemen laut MEDLINE: Biomarkers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The US Preventive Services Task Force recommends providers offer individualized healthy behavior interventions for all adults, independent of their risk of cardiovascular disease. While strong evidence exists to support disease-specific programs designed to improve multiple lifestyle behaviors, approaches to adapting these interventions for a broader population are not well established. Digital behavior change interventions (DBCIs) hold promise as a more generalizable and scalable approach to overcome the resource and time limitations that traditional behavioral intervention programs face, especially within an occupational setting.

Objective

We aimed to evaluate the efficacy of a multimodal DBCI on (1) self-reported behaviors of physical activity, nutrition, sleep, and mindfulness; (2) cardiometabolic biomarkers; and (3) chronic disease–related medical expenditure.

Methods

We conducted a 2-arm randomized controlled trial for 12 months among employees of an academic health care facility in the United States. The intervention arm received a scale, a smartphone app, an activity tracker, a video library for healthy behavior recommendations, and an on-demand health coach. The control arm received standard employer-provided health and wellness benefits. The primary outcomes of the study included changes in self-reported lifestyle behaviors, cardiometabolic biomarkers, and chronic disease–related medical expenditure. We collected health behavior data via baseline and quarterly web-based surveys, biometric measures via clinic visits at baseline and 12 months, and identified relevant costs through claims datasets.

Results

A total of 603 participants were enrolled and randomized to the intervention (n=300, 49.8%) and control arms (n=303, 50.2%). The average age was 46.7 (SD 11.2) years, and the majority of participants were female (80.3%, n=484), White (85.4%, n=504), and non-Hispanic (90.7%, n=547), with no systematic differences in baseline characteristics observed between the study arms. We observed retention rates of 86.1% (n=519) for completing the final survey and 77.9% (n=490) for attending the exit visit.

Conclusions

This study represents the largest and most comprehensive evaluation of DBCIs among participants who were not selected based on their underlying condition to assess its impact on behavior, cardiometabolic biomarkers, and medical expenditure. Trial Registration ClinicalTrials.gov NCT04712383; https://clinicaltrials.gov/study/NCT04712383 International Registered Report Identifier (IRRID) RR1-10.2196/50378

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersHumansFemaleMaleAdultLife StyleHealth ExpendituresHealth BehaviorBehavior TherapyMiddle AgedExerciseCardiovascular DiseasesMobile ApplicationsRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

cardiovascular diseasechronic diseasedigital devicesfitnesshealth behaviorlifestyle changemindfulnessnutritionphysical activitysleep

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.
  • Google LLC, Mountain View, CA, United States.
  • Clinician Experience Office, University of Massachusetts Memorial Health, University of Massachusetts Chan Medical School, Worcester, MA, United States.
  • Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, MA, United States.

ORCID-Profile: Sakeina Howard-Wilson, Jack Ching, Sherri Gentile, Martin Ho, Alex Garcia, Didem Ayturk, Peter Lazar, Nova Hammerquist, David McManus, Bruce Barton, Steven Bird, John Moore, Apurv Soni

Zitieren

APA

Howard-Wilson, S., Ching, J., Gentile, S., Ho, M., Garcia, A., Ayturk, D., Lazar, P., Hammerquist, N., McManus, D., Barton, B., Bird, S., Moore, J., & Soni, A. (2024). Efficacy of a Multimodal Digital Behavior Change Intervention on Lifestyle Behavior, Cardiometabolic Biomarkers, and Medical Expenditure: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/50378

Vancouver

Howard-Wilson S, Ching J, Gentile S, Ho M, Garcia A, Ayturk D, et al. Efficacy of a Multimodal Digital Behavior Change Intervention on Lifestyle Behavior, Cardiometabolic Biomarkers, and Medical Expenditure: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2024. doi:10.2196/50378

BibTeX
@article{HowardWilson2024,
  author = {Howard-Wilson, Sakeina and Ching, Jack and Gentile, Sherri and Ho, Martin and Garcia, Alex and Ayturk, Didem and Lazar, Peter and Hammerquist, Nova and McManus, David and Barton, Bruce and Bird, Steven and Moore, John and Soni, Apurv},
  title = {Efficacy of a Multimodal Digital Behavior Change Intervention on Lifestyle Behavior, Cardiometabolic Biomarkers, and Medical Expenditure: Protocol for a Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2024},
  doi = {10.2196/50378}
}
Kostenlos starten →